Alternatively, a BPC-157 dosage of 400600 mcg/day has proven to be effective when administered via subcutaneous injection in close proximity to the affected region
Typical therapeutic doses can range from 1000 mcg once weekly to monthly
Beyond 28 days, benzyl alcohol degradation accelerates and bacterial inhibition becomes unreliable even under proper refrigeration
Key scientific figures and citations Pentadecapeptide BPC 157, having no toxicity, has been investigated in more than 200 peer-reviewed publications, with consistent reports of beneficial outcomes on tendon, ligament, muscle, gastrointestinal and vascular tissue repair in animal models. Sikiric P
Click here to learn more
Ormsbee, H S 3rd, and J D Fondacaro